loading page

Production of Butyrate and Branched Chain Amino Acid Catabolic Byproducts by CHO Cells in Fed-batch Culture Enhances their Specific Productivity
  • +2
  • Cameron Harrington,
  • Taylor Kalomeris,
  • Michaela Jacobs,
  • Gregory Hiller,
  • Bhanu Chandra Mulukutla
Cameron Harrington
Pfizer Andover

Corresponding Author:[email protected]

Author Profile
Taylor Kalomeris
Author Profile
Michaela Jacobs
Author Profile
Gregory Hiller
Pfizer, Inc.
Author Profile
Bhanu Chandra Mulukutla
Author Profile


Chinese hamster ovary (CHO) cells in fed-batch cultures produce several metabolic byproducts derived from amino acid catabolism, some of which accumulate to growth inhibitory levels. Controlling the accumulation of these byproducts has been shown to significantly enhance cell proliferation. Interestingly, some of these byproducts have physiological roles that go beyond inhibition of cell proliferation. In this study, we show that, in CHO cell fed-batch cultures, branched chain amino acid (BCAA) catabolism contributes to the formation of butyrate, a novel byproduct that is also a well-established specific productivity enhancer. Further, the other byproducts of BCAA catabolism, isovalerate and isobutyrate, which accumulate in CHO cell fed-batch cultures also enhance specific productivity. Additionally, the rate of production of these BCAA catabolic byproducts was negatively correlated with glucose uptake and lactate production rates. Limiting glucose supply to suppress glucose uptake and lactate production, like in case of fed-batch cultures employing HiPDOG technology, significantly enhances BCAA catabolic byproduct accumulation resulting in higher specific productivities.
02 Feb 2021Submitted to Biotechnology and Bioengineering
03 Feb 2021Submission Checks Completed
03 Feb 2021Assigned to Editor
11 Feb 2021Reviewer(s) Assigned
14 Mar 2021Review(s) Completed, Editorial Evaluation Pending
14 Mar 2021Editorial Decision: Revise Major
15 Jun 20211st Revision Received
24 Jun 2021Assigned to Editor
24 Jun 2021Submission Checks Completed
24 Jun 2021Reviewer(s) Assigned
14 Jul 2021Review(s) Completed, Editorial Evaluation Pending
14 Jul 2021Editorial Decision: Revise Major
10 Sep 20212nd Revision Received
11 Sep 2021Submission Checks Completed
11 Sep 2021Assigned to Editor
12 Sep 2021Reviewer(s) Assigned
15 Sep 2021Review(s) Completed, Editorial Evaluation Pending
15 Sep 2021Editorial Decision: Accept
Dec 2021Published in Biotechnology and Bioengineering volume 118 issue 12 on pages 4786-4799. 10.1002/bit.27942